Herein, we hypothesize that in addition to mediate allergic airway inflammation and remodeling, epithelium‐derived triple cytokines, IL‐25/IL‐33/TSLP, can also potentiate non‐atopic lung parenchymal inflammation and fibrogenesis mainly by initiating and propagating type 2 immunity. The gene discussed is TSLP; the disease is inflammation.